IMAX CORPORATION REPORTS Q1 2023 RESULTS
- Global entertainment technology platform drives strong year-over-year growth across all key metrics, including Revenue (+45%), Gross Margin (+58%) and Adjusted EBITDA (+84%)(1)
- System sales climb to 63 signings year-to-date through April — significantly more than the Company delivered in all of 2022 (47)
- Strong global box office performance of
$273 million highlighted by multiple IMAX records, including: - Highest grossing Q1 ever
- Greatest Q1 global market share ever
- Highest grossing quarter ever for local language films
- Highest grossing local language release ever
- Promising upcoming blockbuster slate includes "Guardians of the Galaxy Vol. 3", "Fast X", "The Flash", "Indiana Jones and the Dial of Destiny", and "Mission Impossible — Dead Reckoning Part One"
- Dramatic improvement in Q1 cash flow, with cash from operations of
$21.2 million versus($3.8) million use of cash in Q1 2022
"IMAX is off to an extremely strong start in 2023, with extraordinary growth in system sales and global box office soaring to an all-time record in the first quarter," said
"What's clear in our results is that IMAX is more global than ever. Many of our signings came in high-value, strong box office international markets where we see significant potential to grow our footprint and drive revenue. Furthermore, nearly a third of our record-breaking global box office in the quarter came from non-
"We remain confident we will drive significant growth in 2023 across global box office, system signings, installations, and adjusted EBITDA. And the rapid acceleration of sales activity is a very positive indicator for long-term growth across our global network, box office, and financial results."
(1) |
Non-GAAP Financial Measure. See the discussion at the end of this earnings release for a description of the non-GAAP financial measures used herein, as well as reconciliations to the most comparable GAAP amounts. |
First Quarter Financial Highlights |
|||||||||||
Three Months Ended |
|||||||||||
In millions of |
2023 |
2022 |
YoY % |
||||||||
Total Revenue |
$ |
86.9 |
$ |
60.0 |
45 |
% |
|||||
Gross Margin |
$ |
50.1 |
$ |
31.8 |
58 |
% |
|||||
Gross Margin (%) |
58 |
% |
53 |
% |
|||||||
Net Income (Loss)(2)(3) |
$ |
2.5 |
$ |
(13.6) |
N/A |
||||||
Diluted Net Income (Loss) per share(2)(3) |
$ |
0.04 |
$ |
(0.23) |
N/A |
||||||
Adjusted Net Income (Loss)(1)(2)(3) |
$ |
9.0 |
$ |
(8.2) |
N/A |
||||||
Adjusted Net Income (Loss) per share(1)(2)(3) |
$ |
0.16 |
$ |
(0.14) |
N/A |
||||||
Adjusted EBITDA per Credit Facility(1)(4) |
$ |
27.3 |
$ |
14.8 |
84 |
% |
|||||
Adjusted EBITDA Margin (%)(1)(2) |
34.4 |
% |
27.5 |
% |
25 |
% |
|||||
Weighted average shares outstanding (in millions): |
|||||||||||
Basic |
54.1 |
58.6 |
(8) |
% |
|||||||
Diluted |
55.0 |
58.6 |
(6) |
% |
(1) |
Non-GAAP Financial Measure. See the discussion at the end of this earnings release for a description of the non-GAAP financial measures used herein, as well as reconciliations to the most comparable GAAP amounts. |
|||||
(2) |
Attributable to common shareholders. |
|||||
(3) |
Includes a tax valuation allowance resulting in a negative impact of |
|||||
(4) |
Adjusted EBITDA per Credit facility attributable to common shareholders. |
First Quarter Segment Results(1) |
|||||||||||||||||||||||||
Content Solutions |
Technology Products and Services |
||||||||||||||||||||||||
In millions of |
Revenue |
Gross |
Gross |
Revenue |
Gross |
Gross |
|||||||||||||||||||
1Q23 |
$ |
32.1 |
$ |
18.0 |
56 |
% |
$ |
51.7 |
$ |
29.9 |
58 |
% |
|||||||||||||
1Q22 |
21.0 |
12.6 |
60 |
% |
37.9 |
18.4 |
49 |
% |
|||||||||||||||||
% change |
53 |
% |
43 |
% |
36 |
% |
63 |
% |
(1) |
Please refer to the Company's Form 10-Q for the period ended |
Content Solutions Segment
- Content Solutions revenues of
$32.1 million increased 53% year-over-year. Gross box office from IMAX locations in Q1 2023 of$273.4 million , which was up 58% from Q1 2022. Key contributors to first quarter box office performance included: - Record local language box office contribution of approximately 30%, driven by IMAX's highest ever
Chinese New Year holiday of$61.3 million . - Avatar: The Way of Water delivered over
$109 million in IMAX box office bringing the run total to$250 million , making it IMAX's highest ever first-run release. - Gross margin for Content Solutions was
$18.0 million , at a 56% margin, an increase of 43% compared to the prior year period.
Technology Products and Services Segment
- Technology Products and Services revenues and gross margin increased 36% to
$51.7 million and 63% to$29.9 million , respectively, which reflects growth in box office tied rental revenues as well as a higher number of sale/hybrid installs and renewals. - During the first quarter the Company installed 9 systems compared to 14 systems in the first quarter of 2022. Of those, 8 systems were under sales, sales-type lease and hybrid JRSA arrangements compared to 7 systems in the prior year.
Operating Cash Flow and Liquidity
Net cash provided by operating activities was
As of
Share Count and Capital Return
The weighted average basic and diluted shares outstanding in the first quarter of 2023 were 54.0 million and 55.0 million, respectively, compared to 58.6 million in the first quarter of 2022.
During the first quarter of 2023, the Company repurchased 0.1 million common shares at an average price of
In 2021, the Company issued
As of
Supplemental Materials
For more information about the Company's results, please refer to the IMAX Investor Relations website located at investors.imax.com.
Investor Relations Website and Social Media
On a weekly basis, the Company posts quarter-to-date box office results on the IMAX Investor Relations website located at investors.imax.com. The Company expects to provide such updates on Friday of each week, although the Company may change this timing without notice. Results will be displayed with a one-week lag.
The Company may post additional information on the Company's corporate and Investor Relations website which may be material to investors. Accordingly, investors, media and others interested in the Company should monitor the Company's website in addition to the Company's press releases,
Conference Call
The Company will host a conference call today at
About
IMAX, an innovator in entertainment technology, combines proprietary software, architecture, and equipment to create experiences that take you beyond the edge of your seat to a world you've never imagined. Top filmmakers and studios are utilizing IMAX systems to connect with audiences in extraordinary ways, and, as such, IMAX's network is among the most important and successful theatrical distribution platforms for major event films around the globe.
IMAX is headquartered in
IMAX®, IMAX® 3D, Experience It In IMAX®, The IMAX Experience®, DMR®, Filmed For IMAXTM, IMAX LiveTM, IMAX Enhanced®, and SSIMWAVE® are trademarks and trade names of the Company or its subsidiaries that are registered or otherwise protected under laws of various jurisdictions. More information about the Company can be found at www.imax.com. You may also connect with IMAX on Instagram (https://www.instagram.com/imax), Facebook (www.facebook.com/imax), Twitter (www.twitter.com/imax) and YouTube (www.youtube.com/imaxmovies).
For additional information please contact:
Investors: 212-821-0154 |
Media: 212-821-0102 |
Forward-Looking Statements
This earnings release contains forward looking statements that are based on IMAX management's assumptions and existing information and involve certain risks and uncertainties which could cause actual results to differ materially from future results expressed or implied by such forward looking statements. These forward-looking statements include, but are not limited to, references to business and technology strategies and measures to implement strategies, competitive strengths, goals, expansion and growth of business, operations and technology, future capital expenditures (including the amount and nature thereof), industry prospects and consumer behavior, plans and references to the future success of
Primary Reporting Groups
The Company's Chief Executive Officer ("CEO") is its Chief Operating Decision Maker ("CODM"), as such term is defined under
In the first quarter of 2023, the Company revised its internal segment reporting, including the information provided to the CODM to assess segment performance and allocate resources. Accordingly, the Company has two reportable segments: (i) Content Solutions, which principally includes content enhancement and distribution services, previously included within the IMAX DMR, Film Distribution and Film Post-Production segments, and (ii) Technology Products and Services, which principally includes the sale, lease, and maintenance of IMAX Systems, previously included within the JRSA, IMAX Systems, IMAX Maintenance, and Other Theater Business segments. The Company's activities that do not meet the criteria to be considered a reportable segment are reported within All Other. Prior period comparatives have been revised to conform with the current period presentation.
The Company has the following reportable segments:
(i) |
Content Solutions, which principally includes the digital remastering of films and other content into IMAX formats for distribution to the IMAX network. To a lesser extent, the Content Solutions segment also earns revenue from the distribution of large-format documentary films and exclusive experiences ranging from live performances to interactive events with leading artists and creators, as well as film post-production services. |
(ii) |
Technology Products and Services, which includes results from the sale or lease of IMAX Systems, as well as from the maintenance of IMAX Systems. To a lesser extent, the Technology Product and Services segment also earns revenue from certain ancillary theater business activities, including after-market sales of IMAX System parts and 3D glasses. |
Transactions between segments are valued at exchange value. Inter-segment profits are eliminated upon consolidation, as well as for the disclosures below.
IMAX Network and Backlog |
|||||||||
Three Months Ended |
|||||||||
System Signings: |
2023 |
2022 |
|||||||
New IMAX Systems |
|||||||||
Sales and sales-type lease arrangements |
14 |
4 |
|||||||
Hybrid JRSA |
— |
1 |
|||||||
Traditional JRSA |
13 |
2 |
|||||||
Total new IMAX Systems |
27 |
7 |
|||||||
Upgrades of IMAX systems |
1 |
— |
|||||||
Total IMAX System signings |
28 |
7 |
|||||||
Three Months Ended |
|||||||||
System Installations: |
2023 |
2022 |
|||||||
New IMAX Systems |
|||||||||
Sales and sales-type lease arrangements |
7 |
4 |
|||||||
Hybrid JRSA |
— |
2 |
|||||||
Traditional JRSA |
— |
6 |
|||||||
Total new IMAX Systems |
7 |
12 |
|||||||
Upgrades of IMAX Systems |
2 |
2 |
|||||||
Total IMAX System installations |
9 |
14 |
|||||||
|
|||||||||
IMAX System Backlog: |
2023 |
2022 |
|||||||
Sales and sales-type lease arrangements |
170 |
171 |
|||||||
Hybrid JRSA |
118 |
131 |
|||||||
Traditional JRSA |
180 |
185 |
|||||||
Total IMAX System backlog |
468 |
487 |
|||||||
|
|||||||||
IMAX Network: |
2023 |
2022 |
|||||||
|
|||||||||
Sales and sales-type lease arrangements |
704 |
691 |
|||||||
Hybrid JRSA |
149 |
148 |
|||||||
Traditional JRSA |
778 |
767 |
|||||||
|
1,631 |
1,606 |
|||||||
|
12 |
12 |
|||||||
|
68 |
72 |
|||||||
Total IMAX network |
1,711 |
1,690 |
|
|||||||||
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS |
|||||||||
(In thousands of |
|||||||||
(Unaudited) |
|||||||||
Three Months Ended |
|||||||||
|
|||||||||
2023 |
2022 |
||||||||
Revenues |
|||||||||
Technology sales |
$ |
17,822 |
$ |
8,976 |
|||||
Image enhancement and maintenance services |
47,127 |
36,094 |
|||||||
Technology rentals |
20,058 |
12,661 |
|||||||
Finance income |
1,939 |
2,305 |
|||||||
86,946 |
60,036 |
||||||||
Costs and expenses applicable to revenues |
|||||||||
Technology sales |
7,232 |
5,985 |
|||||||
Image enhancement and maintenance services |
23,085 |
15,743 |
|||||||
Technology rentals |
6,578 |
6,537 |
|||||||
36,895 |
28,265 |
||||||||
Gross margin |
50,051 |
31,771 |
|||||||
Selling, general and administrative expenses |
34,148 |
30,181 |
|||||||
Research and development |
1,855 |
1,197 |
|||||||
Amortization of intangible assets |
1,074 |
1,196 |
|||||||
Credit loss expense, net |
220 |
7,229 |
|||||||
Executive transition costs |
1,353 |
- |
|||||||
Income (loss) from operations |
11,401 |
(8,032) |
|||||||
Realized and unrealized investment gains |
44 |
34 |
|||||||
Retirement benefits non-service expense |
(77) |
(139) |
|||||||
Interest income |
407 |
502 |
|||||||
Interest expense |
(1,767) |
(1,705) |
|||||||
Income (loss) before taxes |
10,008 |
(9,340) |
|||||||
Income tax expense |
(4,885) |
(2,610) |
|||||||
Net income (loss) |
5,123 |
(11,950) |
|||||||
Less: net income attributable to non-controlling interests |
(2,669) |
(1,659) |
|||||||
Net income (loss) attributable to common shareholders |
$ |
2,454 |
$ |
(13,609) |
|||||
Net income (loss) per share attributable to common shareholders - basic and diluted: |
|||||||||
Net income (loss) per share attributable to common shareholders — basic |
$ |
0.05 |
$ |
(0.23) |
|||||
Net income (loss) per share attributable to common shareholders — diluted |
$ |
0.04 |
$ |
(0.23) |
|||||
Weighted average shares outstanding — basic (in thousands) |
54,064 |
58,574 |
|||||||
Weighted average shares outstanding — diluted (in thousands) |
54,991 |
58,574 |
|||||||
Additional Disclosure: |
|||||||||
Depreciation and amortization |
$ |
13,320 |
$ |
12,741 |
|||||
Amortization of deferred financing costs |
$ |
625 |
$ |
1,023 |
|
||||||||
CONDENSED CONSOLIDATED BALANCE SHEETS |
||||||||
(In thousands of |
||||||||
(Unaudited) |
||||||||
|
|
|||||||
2023 |
2022 |
|||||||
Assets |
||||||||
Cash and cash equivalents |
$ |
99,246 |
$ |
97,401 |
||||
Accounts receivable, net of allowance for credit losses |
123,382 |
136,142 |
||||||
Financing receivables, net of allowance for credit losses |
131,187 |
129,384 |
||||||
Variable consideration receivables, net of allowance for credit losses |
47,380 |
44,024 |
||||||
Inventories |
37,492 |
31,534 |
||||||
Prepaid expenses |
14,296 |
12,343 |
||||||
Film assets, net of accumulated amortization |
6,347 |
5,277 |
||||||
Property, plant and equipment, net of accumulated depreciation |
248,279 |
252,896 |
||||||
Investment in equity securities |
1,050 |
1,035 |
||||||
Other assets |
15,480 |
15,665 |
||||||
Deferred income tax assets, net of valuation allowance |
11,218 |
9,900 |
||||||
|
52,815 |
52,815 |
||||||
Other intangible assets, net of accumulated amortization |
33,349 |
32,738 |
||||||
Total assets |
$ |
821,521 |
$ |
821,154 |
||||
Liabilities |
||||||||
Accounts payable |
$ |
25,783 |
$ |
25,237 |
||||
Accrued and other liabilities |
113,729 |
117,286 |
||||||
Deferred revenue |
73,550 |
70,940 |
||||||
Revolving credit facility borrowings, net of unamortized debt issuance costs |
31,025 |
36,111 |
||||||
Convertible notes and other borrowings, net of unamortized discounts and debt issuance costs |
227,549 |
226,912 |
||||||
Deferred income tax liabilities |
16,046 |
14,900 |
||||||
Total liabilities |
487,682 |
491,386 |
||||||
Commitments, contingencies and guarantees |
||||||||
Non-controlling interests |
731 |
722 |
||||||
Shareholders' equity |
||||||||
Capital stock common shares — no par value. Authorized — unlimited number. |
||||||||
54,589,933 issued and outstanding ( |
389,500 |
376,715 |
||||||
Other equity |
170,871 |
185,678 |
||||||
Statutory surplus reserve |
3,932 |
3,932 |
||||||
Accumulated deficit |
(292,409) |
(293,124) |
||||||
Accumulated other comprehensive loss |
(7,876) |
(9,846) |
||||||
Total shareholders' equity attributable to common shareholders |
264,018 |
263,355 |
||||||
Non-controlling interests |
69,090 |
65,691 |
||||||
Total shareholders' equity |
333,108 |
329,046 |
||||||
Total liabilities and shareholders' equity |
$ |
821,521 |
$ |
821,154 |
|
||||||||||
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS |
||||||||||
(In thousands of |
||||||||||
(Unaudited) |
||||||||||
Three Months Ended |
||||||||||
|
||||||||||
2023 |
2022 |
|||||||||
Operating Activities |
||||||||||
Net income (loss) |
$ |
5,123 |
$ |
(11,950) |
||||||
Adjustments to reconcile net income (loss) to cash provided by (used in) operating |
||||||||||
Depreciation and amortization |
13,320 |
12,741 |
||||||||
Amortization of deferred financing costs |
625 |
1,023 |
||||||||
Credit loss expense, net |
220 |
7,229 |
||||||||
Write-downs |
304 |
381 |
||||||||
Deferred income tax benefit |
(193) |
(109) |
||||||||
Share-based and other non-cash compensation |
5,135 |
6,189 |
||||||||
Unrealized foreign currency exchange (gain) loss |
(78) |
58 |
||||||||
Realized and unrealized investment gains |
(44) |
(34) |
||||||||
Changes in assets and liabilities: |
||||||||||
Accounts receivable |
12,374 |
(2,654) |
||||||||
Inventories |
(5,946) |
(534) |
||||||||
Film assets |
(3,884) |
(5,107) |
||||||||
Deferred revenue |
2,606 |
(830) |
||||||||
Changes in other operating assets and liabilities |
(8,344) |
(10,186) |
||||||||
Net cash provided by (used in) operating activities |
21,218 |
(3,783) |
||||||||
Investing Activities |
||||||||||
Purchase of property, plant and equipment |
(364) |
(728) |
||||||||
Investment in equipment for joint revenue sharing arrangements |
(2,157) |
(4,587) |
||||||||
Interest in film classified as a financial instrument |
— |
(4,731) |
||||||||
Acquisition of other intangible assets |
(1,760) |
(551) |
||||||||
Net cash used in investing activities |
(4,281) |
(10,597) |
||||||||
Financing Activities |
||||||||||
Revolving credit facility borrowings |
25,717 |
— |
||||||||
Repayments of revolving credit facility borrowings |
(31,180) |
— |
||||||||
Credit facility amendment fees paid |
— |
(1,783) |
||||||||
Other borrowings |
315 |
— |
||||||||
Repurchase of common shares |
(3,656) |
(6,272) |
||||||||
Repurchase of common shares, IMAX China |
— |
(1,844) |
||||||||
Taxes withheld and paid on employee stock awards vested |
(6,233) |
(3,136) |
||||||||
Net cash used in financing activities |
(15,037) |
(13,035) |
||||||||
Effects of exchange rate changes on cash |
(55) |
4 |
||||||||
Increase (decrease) in cash and cash equivalents during period |
1,845 |
(27,411) |
||||||||
Cash and cash equivalents, beginning of period |
97,401 |
189,711 |
||||||||
Cash and cash equivalents, end of period |
$ |
99,246 |
$ |
162,300 |
Segment Revenue and Gross Margin |
||||||||
Three Months Ended |
||||||||
|
||||||||
(In thousands of |
2023 |
2022 |
||||||
Revenue |
||||||||
Content Solutions |
$ |
32,101 |
$ |
20,988 |
||||
Technology Products and Services |
51,667 |
37,863 |
||||||
Sub-total for reportable segments |
83,768 |
58,851 |
||||||
All Other(1) |
3,178 |
1,185 |
||||||
Total |
$ |
86,946 |
$ |
60,036 |
||||
Gross Margin |
||||||||
Content Solutions |
$ |
17,995 |
$ |
12,625 |
||||
Technology Products and Services |
29,891 |
18,416 |
||||||
Sub-total for reportable segments |
47,886 |
31,041 |
||||||
All Other(1) |
2,165 |
730 |
||||||
Total |
$ |
50,051 |
$ |
31,771 |
(1) |
All Other includes the results from IMAX Enhanced, SSIMWAVE, and other ancillary activities. |
NON-GAAP FINANCIAL MEASURES
(in thousands of
In this release, the Company presents adjusted net income (loss) attributable to common shareholders and adjusted net income (loss) attributable to common shareholders per basic and diluted share, EBITDA, Adjusted EBITDA per Credit Facility, Adjusted EBITDA margin as supplemental measures of the Company's performance, which are not recognized under
The Company believes that these non-GAAP financial measures are important supplemental measures that allow management and users of the Company's financial statements to view operating trends and analyze controllable operating performance on a comparable basis between periods without the after-tax impact of share-based compensation and certain unusual items included in net income (loss) attributable to common shareholders. Although share-based compensation is an important aspect of the Company's employee and executive compensation packages, it is a non-cash expense and is excluded from certain internal business performance measures.
A reconciliation from net income (loss) attributable to common shareholders and the associated per share amounts to adjusted net income (loss) attributable to common shareholders and adjusted net income (loss) attributable to common shareholders per basic and diluted share are presented in the table below. Net income (loss) attributable to common shareholders and the associated per share amounts are the most directly comparable GAAP measures because they reflect the earnings relevant to the Company's shareholders, rather than the earnings attributable to non-controlling interests.
In addition to the non-GAAP financial measures discussed above, management also uses "EBITDA," as well as "Adjusted EBITDA per Credit Facility," as defined in the Company's Credit Agreement. As allowed by the Credit Agreement, Adjusted EBITDA per Credit Facility includes adjustments in addition to the exclusion of interest, taxes, depreciation and amortization. Accordingly, this non-GAAP financial measure is presented to allow a more comprehensive analysis of the Company's operating performance and to provide additional information with respect to the Company's compliance against its Credit Agreement requirements, when applicable. In addition, the Company believes that Adjusted EBITDA per Credit Facility presents relevant and useful information widely used by analysts, investors and other interested parties in the Company's industry to evaluate, assess and benchmark the Company's results.
EBITDA is defined as net income or loss excluding (i) income tax expense or benefit; (ii) interest expense, net of interest income; (iii) depreciation and amortization, including film asset amortization; and (iv) amortization of deferred financing costs. Adjusted EBITDA per Credit Facility is defined as EBITDA excluding: (i) share-based and other non-cash compensation; (ii) realized and unrealized investment gains or losses; (iii) acquisition-related expenses; (iv) legal judgment and arbitration awards; (v) executive transition costs, and (vi) write-downs, net of recoveries, including asset impairments and credit loss expense.
A reconciliation of net income (loss) attributable to common shareholders, which is the most directly comparable GAAP measure, to EBITDA and Adjusted EBITDA per Credit Facility is presented in the table below. Net income (loss) attributable to common shareholders is the most directly comparable GAAP measure because it reflects the earnings relevant to the Company's shareholders, rather than the earnings attributable to non-controlling interests.
In this release, the Company also presents free cash flow, which is not recognized under
These non-GAAP measures may not be comparable to similarly titled amounts reported by other companies. Additionally, the non-GAAP financial measures used by the Company should not be considered as a substitute for, or superior to, the comparable GAAP amounts.
Adjusted EBITDA per Credit Facility |
||||||||||||||||||||||||
For the Three Months Ended |
For the Three Months Ended |
|||||||||||||||||||||||
Attributable to |
Attributable to |
|||||||||||||||||||||||
Non-controlling |
Less: |
Non-controlling |
Less: |
|||||||||||||||||||||
Interests and |
Attributable to |
Attributable to |
Interests and |
Attributable to |
Attributable to |
|||||||||||||||||||
(In thousands of |
Common |
Non-controlling |
Common |
Common |
Non-controlling |
Common |
||||||||||||||||||
Reported net income (loss) |
$ |
5,123 |
$ |
2,669 |
$ |
2,454 |
$ |
(11,950) |
$ |
1,659 |
$ |
(13,609) |
||||||||||||
Add (subtract): |
||||||||||||||||||||||||
Income tax expense |
4,885 |
793 |
4,092 |
2,610 |
487 |
2,123 |
||||||||||||||||||
Interest expense, net of interest income |
735 |
(11) |
746 |
180 |
(106) |
286 |
||||||||||||||||||
Depreciation and amortization, including film asset |
13,320 |
1,301 |
12,019 |
12,741 |
1,301 |
11,440 |
||||||||||||||||||
Amortization of deferred financing costs(1) |
625 |
— |
625 |
1,023 |
— |
1,023 |
||||||||||||||||||
EBITDA |
$ |
24,688 |
$ |
4,752 |
$ |
19,936 |
$ |
4,604 |
$ |
3,341 |
$ |
1,263 |
||||||||||||
Share-based and other non-cash compensation |
5,633 |
194 |
5,439 |
6,189 |
203 |
5,986 |
||||||||||||||||||
Unrealized investment gains |
(44) |
— |
(44) |
(34) |
— |
(34) |
||||||||||||||||||
Acquisition-related expenses |
156 |
— |
156 |
— |
— |
— |
||||||||||||||||||
Write-downs, including asset impairments and credit |
524 |
82 |
442 |
7,610 |
18 |
7,592 |
||||||||||||||||||
Executive transition costs |
1,353 |
— |
1,353 |
— |
— |
— |
||||||||||||||||||
Adjusted EBITDA per Credit Facility |
$ |
32,310 |
$ |
5,028 |
$ |
27,282 |
$ |
18,369 |
$ |
3,562 |
$ |
14,807 |
||||||||||||
Revenues attributable to common shareholders(2) |
$ |
86,946 |
$ |
7,537 |
$ |
79,409 |
$ |
60,036 |
$ |
6,140 |
$ |
53,896 |
||||||||||||
Adjusted EBITDA margin attributable to common |
37.2 % |
66.7 % |
34.4 % |
30.6 % |
58.0 % |
27.5 % |
||||||||||||||||||
For the Twelve Months Ended |
For the Twelve Months Ended |
|||||||||||||||||||||||
Attributable to |
Attributable to |
|||||||||||||||||||||||
Non-controlling |
Less: |
Non-controlling |
Less: |
|||||||||||||||||||||
Interests and |
Attributable to |
Attributable to |
Interests and |
Attributable to |
Attributable to |
|||||||||||||||||||
(In thousands of |
Common |
Non-controlling |
Common |
Common |
Non-controlling |
Common |
||||||||||||||||||
Reported net (loss) income |
$ |
(2,804) |
$ |
3,933 |
$ |
(6,737) |
$ |
(11,027) |
$ |
10,071 |
$ |
(21,098) |
||||||||||||
Add (subtract): |
||||||||||||||||||||||||
Income tax expense |
12,382 |
1,562 |
10,820 |
20,106 |
3,562 |
16,544 |
||||||||||||||||||
Interest expense, net of interest income |
1,827 |
(156) |
1,983 |
1,130 |
(376) |
1,506 |
||||||||||||||||||
Depreciation and amortization, including film asset |
57,240 |
4,820 |
52,420 |
56,146 |
5,407 |
50,739 |
||||||||||||||||||
Amortization of deferred financing costs(1) |
2,779 |
— |
2,779 |
3,227 |
— |
3,227 |
||||||||||||||||||
EBITDA |
$ |
71,424 |
$ |
10,159 |
$ |
61,265 |
$ |
69,582 |
$ |
18,664 |
$ |
50,918 |
||||||||||||
Share-based and other non-cash compensation |
27,017 |
751 |
26,266 |
26,847 |
1,071 |
25,776 |
||||||||||||||||||
Unrealized investment gains |
(81) |
— |
(81) |
(126) |
— |
(126) |
||||||||||||||||||
Acquisition-related expenses |
1,278 |
— |
1,278 |
— |
— |
— |
||||||||||||||||||
Write-downs, including asset impairments and credit |
8,638 |
1,787 |
6,851 |
4,905 |
(961) |
5,866 |
||||||||||||||||||
Legal judgement and arbitration awards |
— |
— |
— |
(1,770) |
— |
(1,770) |
||||||||||||||||||
Executive transition costs |
1,353 |
— |
1,353 |
— |
— |
— |
||||||||||||||||||
Adjusted EBITDA per Credit Facility |
$ |
109,629 |
$ |
12,697 |
$ |
96,932 |
$ |
99,438 |
$ |
18,774 |
$ |
80,664 |
||||||||||||
Revenues attributable to common shareholders(2) |
$ |
327,715 |
$ |
22,280 |
$ |
305,435 |
$ |
276,165 |
$ |
31,997 |
$ |
244,168 |
||||||||||||
Adjusted EBITDA margin attributable to common |
33.5 % |
57.0 % |
31.7 % |
36.0 % |
58.7 % |
33.0 % |
(1) |
The amortization of deferred financing costs is recorded within Interest Expense in the Condensed Consolidated Statement of Operations. |
|||||
(2) |
Revenues attributable to common shareholders calculated as follows: |
Three months ended |
Three months ended |
Twelve months ended |
Twelve months ended |
|||||||||||||||||||||||||||||||||||
(In thousands of |
|
|
|
|
||||||||||||||||||||||||||||||||||
Total revenues |
$ |
86,946 |
$ |
60,036 |
$ |
327,715 |
$ |
276,165 |
||||||||||||||||||||||||||||||
|
$ |
26,566 |
$ |
21,476 |
$ |
78,420 |
$ |
108,759 |
||||||||||||||||||||||||||||||
Non-controlling interest ownership percentage(3) |
28.37 % |
28.59 % |
28.41 % |
29.42 % |
||||||||||||||||||||||||||||||||||
Deduction for non-controlling interest share of |
(7,537) |
(6,140) |
(22,280) |
(31,997) |
||||||||||||||||||||||||||||||||||
Revenues attributable to common shareholders |
$ |
79,409 |
$ |
53,896 |
$ |
305,435 |
$ |
244,168 |
(3) |
Weighted average ownership percentage for change in non-controlling interest share. |
Adjusted Net Income (Loss) Attributable to Common Shareholders and Adjusted Net Income (Loss) Per Diluted Share |
||||||||||||||||
Three Months Ended |
||||||||||||||||
2023 |
2022 |
|||||||||||||||
(In thousands of |
Net Income |
Per Share |
Net Loss |
Per Share |
||||||||||||
Net income (loss) attributable to common shareholders |
$ |
2,454 |
$ |
0.04 |
$ |
(13,609) |
$ |
(0.23) |
||||||||
Adjustments(1): |
||||||||||||||||
Share-based compensation |
5,536 |
0.10 |
5,959 |
0.10 |
||||||||||||
COVID-19 government relief benefits, net |
— |
— |
(193) |
— |
||||||||||||
Unrealized investment gains |
(45) |
— |
(34) |
— |
||||||||||||
Acquisition-related expenses |
156 |
— |
— |
— |
||||||||||||
Executive transition costs |
1,353 |
0.02 |
— |
— |
||||||||||||
Tax impact on items listed above |
(429) |
(0.01) |
(367) |
(0.01) |
||||||||||||
Adjusted net income (loss)(1) |
$ |
9,025 |
$ |
0.16 |
$ |
(8,244) |
$ |
(0.14) |
||||||||
Weighted average shares outstanding — basic |
54,064 |
58,574 |
||||||||||||||
Weighted average shares outstanding — diluted |
54,991 |
58,574 |
(1) |
Reflects amounts attributable to common shareholders. |
Free Cash Flow |
|||||
Three Months Ended |
|||||
(In thousands of |
|
||||
Net cash provided by operating activities |
$ |
21,218 |
|||
Net cash used in investing activities |
(4,281) |
||||
Free cash flow |
$ |
16,937 |
View original content to download multimedia:https://www.prnewswire.com/news-releases/imax-corporation-reports-q1-2023-results-301810172.html
SOURCE